Cellular senescence in testicular cancer. Is there a correlation with the preoperative markers and the extent of the tumor? An experimental study-Reference-Cited by-同舟云学术

Cellular senescence in testicular cancer. Is there a correlation with the preoperative markers and the extent of the tumor? An experimental study

Published:2024-03-04 Issue:1 Volume:96 Page:
ISSN:2282-4197
Container-title:Archivio Italiano di Urologia e Andrologia
language:
Short-container-title:Arch Ital Urol Androl

Author:

Tatanis Vasileios^ORCID,Veroutis Dimitris,Pantelis Pavlos,Theocharous George^ORCID,Sarlanis Helen^ORCID,Georgiou Alexandros,Peteinaris Angelis^ORCID,Natsos Anastasios^ORCID,Moulavasilis Napoleon^ORCID,Kavantzas Nikolaos,Kotsinas Athanassios,Adamakis Ioannis

Abstract

Purpose: The aim of this experimental study is to investigate the correlation between the presence of senescent cells and the tumor size, the lymphovascular invasion (LVI), the invasion of rete testis (RTI), the preoperative tumor markers or pathological stage in patients who underwent orchiectomy for malignant purposes. Methods: This experimental study included patients with a history of radical orchiectomy performed from January 2011 to January 2019. The testicular tissue specimens underwent an immunohistopathological process for the detection of the presence of cellular senescence. Besides, the tumor size, the histopathological type, the pathological stage of the tumor and the presence of Lymphovascular (LVI) or rete testis (RTI) invasions were also recorded. Additionally, the preoperative serum levels of alpha-fetoprotein, beta-human chorionic gonadotropin and lactate dehydrogenase were recorded. After the completion of immunohistochemical analysis, the rate of senescent cells in each specimen was also recorded. Results: The mean senescent cell rate was estimated to be 14.11±11.32% and 15.46±10.58% in patients with presence of LVI or absence of LVI, respectively (p=0.46). The mean senescent cell rate was calculated at 18.13±12.26% and 12.56±9.38% (p=0.096) in patients with presence of RTI or absence of RTI, respectively. The mean senescent cell rate in the pT1 group was calculated at 14.58 ± 9.82%, while in T2 and T3 groups the mean senescent cell rate was estimated to be 15.22 ± 12.03% and 15.35 ± 14.21%, respectively (p=0.98). A statistically significant correlation was detected between the senescence rate and the tumor size (Pearson score 0.40, p=0.027) and between the rate of senescent cells and the preoperative level of lactate dehydrogenase (LDH) (Pearson score -0.53, p=0.002).Conclusions: The presence of cellular senescence was correlated with the extent of the testicular tumor in terms of tumor size as well as the preoperative level of the LDH serum marker.

Publisher

PAGEPress Publications

Reference26 articles.

1. Biggs ML SS. Cancer of the testis. In: LAG Ries, J Young, GE Keel, et al., Editors. SEER survival monograph: cancer survival among adults: US SEER Program, 1988-2001, patient and tumor characteristics. National Cancer Institute, Bethesda: 2007; p. 165-70.

2. EAU Guidelines. Presented at the EAU Annual Congress Milan 2023. EAU Guidelines Office, Arnhem, the Netherlands.

3. Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS. Role of biochemical markers in testicular cancer: diagnosis, staging, andsurveillance. Open Access J Urol. 2011;4:1-8.

4. Germa-Lluch JR, Garcia del Muro X, Maroto P, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002 42:553-62.

5. Lempiainen A, Stenman UH, Blomqvist C, Hotakainen K. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer. Clin Chem. 2008;54:1840-3.